Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be available in Hong Kong from St. Teresa's Hospital by ...

Cra-Z-Art announced a plan to significantly increase toy manufacturing in the U.S. to combat the cost of tariffs for imported ...

Accelleron Industries AG / Key word (s): Annual Results Accelleron breaks through the USD 1 billion revenue mark 13-March-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR ...

This is despite South Africa having the world's biggest antiretroviral therapy (ART) system ... Lenacapavir, an annual injection meant to protect against HIV, has completed an essential early ...

Ford and Chevrolet wage one of the most intense rivalries in the auto world. The roots of the conflict go back nearly as long ...

A Texas appeals court on Tuesday halted the execution of a man who has spent more than 30 years on death row and had been set ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...